943PDResponse to neoadjuvant chemotherapy in ICON8: A GCIG phase III randomised trial evaluating weekly dose-dense chemotherapy integration in first-line epithelial ovarian/ fallopian tube/ primary peritoneal carcinoma (EOC) treatment. (23rd October 2018) - Clamp, A R; McNeish, I A; Dean, A; Gallardo-Rincon, D; Kim, J-W; O'Donnell, D M; Hook, J; Blagden, S; Brenton, J D; Naik, R; Perren, T J; Sundar, S; et al.